| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/25/2014 | WO2014147622A1 Compositions comprising collagen and prp for tissue regeneration |
| 09/25/2014 | WO2014147526A1 Tofacitinib oral sustained release dosage forms |
| 09/25/2014 | WO2014146575A1 Antibodies and methods for treating estrogen receptor-associated diseases |
| 09/25/2014 | WO2014146491A1 Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors |
| 09/25/2014 | WO2014146345A1 Tonic wine for dispelling rheumatism |
| 09/25/2014 | WO2014146249A1 Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors |
| 09/25/2014 | US20140288266 Synthesis of Cyclosporin Analogs |
| 09/23/2014 | US8841447 Process for the preparation of alogliptin |
| 09/23/2014 | US8841433 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 09/23/2014 | US8840913 Malleable multi-component implants and materials therefor |
| 09/23/2014 | CA2732058C Anti-aging or antioxidant composition containing plant stem cell line derived from cambium of panax ginseng |
| 09/23/2014 | CA2683009C Use of il-18 inhibitors |
| 09/23/2014 | CA2648460C Calcium phosphate complex and salts in oral delivery systems |
| 09/23/2014 | CA2548990C Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 09/23/2014 | CA2441815C Method and composition for treatment of skeletal dysplasias |
| 09/18/2014 | WO2014146044A1 Administration of nicotinamide mononucleotide in the treatment of disease |
| 09/18/2014 | WO2014144888A1 Calcium sulfate-resin hybrid materials and methods of using and making the same |
| 09/18/2014 | WO2014143943A1 Preparations containing hepatocyte growth factor and hyaluronic acid, and methods of making and using same |
| 09/18/2014 | WO2014141877A1 Tissue repair material |
| 09/18/2014 | WO2014141847A1 Therapeutic agent for systemic bone disease and use thereof |
| 09/18/2014 | WO2014141244A1 Synthetic peptides for the treatment of autoimmune diseases |
| 09/18/2014 | WO2014140597A1 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoromet hyl)benzyl)quinazolin-4(3h)-one derivatives and their use as phosphoinositide 3-kinase inhibitors |
| 09/18/2014 | WO2014140299A1 Macrocyclic rip2 kinase inhibitors |
| 09/18/2014 | WO2014140091A1 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c |
| 09/18/2014 | WO2014140065A1 N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals |
| 09/18/2014 | WO2014139425A1 Anti-blys monoclonal antibody and pharmaceutical composition containing antibody |
| 09/18/2014 | WO2014138907A1 Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis |
| 09/18/2014 | WO2014138906A1 Substituted aromatic compounds and related method for the treatment of fibrosis |
| 09/18/2014 | US20140275618 Therapeutic compounds and methods of use |
| 09/18/2014 | US20140275479 Specific binding agents of human angiopoeitin-2 |
| 09/18/2014 | US20140271868 Treatment of achondroplasia with encapsulated cnp-secreting cells |
| 09/18/2014 | US20140271735 Use of calcitonin in osteoarthritis |
| 09/18/2014 | US20140271637 Methods of administering anti-tnfalpha antibodies |
| 09/17/2014 | EP2777403A1 Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring |
| 09/17/2014 | EP2776393A1 Nampt inhibitors |
| 09/17/2014 | EP2776129A1 Calcimimetics and methods for their use |
| 09/17/2014 | EP2776044A1 Pharmaceutical compositions comprising lubricants for preventing or reducing aseptic loosening in a subject |
| 09/17/2014 | EP2776028A1 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| 09/17/2014 | EP2776027A1 Nadph oxidase 4 inhibitors and use thereof |
| 09/16/2014 | US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 09/16/2014 | US8835390 Modulation of osteoclast differentiation |
| 09/16/2014 | US8835389 Use of calcitonin for the treatment of RA |
| 09/16/2014 | US8834937 Bone filling material comprising sintered titanium dioxide and dextrin and method for reconstructing bone defects using the same |
| 09/16/2014 | US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 09/16/2014 | US8834876 Therapeutic agent for hematopoietic tumors |
| 09/16/2014 | CA2673337C Bone growth particles and osteoinductive composition thereof |
| 09/12/2014 | WO2014138712A1 Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis |
| 09/12/2014 | WO2014138612A1 Consistent calcium content bone allograft systems and methods |
| 09/12/2014 | WO2014138372A1 Composition and method for treating osteoarthritis |
| 09/12/2014 | WO2014137961A1 Anti-tnf-anti-il-17 bispecific antibodies |
| 09/12/2014 | WO2014135841A1 Nanoparticle peptide compositions |
| 09/12/2014 | WO2014135834A1 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator |
| 09/12/2014 | WO2014135529A1 Mixture of fatty acids for use in the treatment of inflammatory pathologies |
| 09/12/2014 | WO2014107745A9 Metal sensitive mutants of matrix metalloproteases and uses thereof |
| 09/11/2014 | US20140256743 Cathepsin cysteine protease inhibitors |
| 09/11/2014 | US20140256632 Methods useful in the treatment of bone resorption diseases |
| 09/11/2014 | US20140255493 Extrudate and methods of using said extrudate |
| 09/10/2014 | EP2774609A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 09/10/2014 | EP2773645A1 Imidazopyridazine compounds |
| 09/10/2014 | EP2773378A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids) |
| 09/10/2014 | EP2773358A1 Compositions and methods for hemostasis |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828947 Polypeptide formulation |
| 09/09/2014 | US8828941 Composition and method for the treatment or prevention of spinal disorders |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828385 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 09/09/2014 | US8828375 Expansion of haemopoietic precursors |
| 09/04/2014 | US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells |
| 09/04/2014 | US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 09/03/2014 | EP2772540A1 Method for detecting specific single nucleotide polymorphism related to ankylosing spondylitis and kit therefor |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2772490A1 Aminoalkyl-substituted n-thienyl benzamide derivative |
| 09/03/2014 | EP2772484A1 Bicyclic heterocyclic compound |
| 09/03/2014 | EP2772250A1 Enteric composition for the manufacture of soft capsule wall |
| 09/03/2014 | EP2771360A1 Immunobinders directed against sclerostin |
| 09/03/2014 | EP2771334A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies |
| 09/03/2014 | EP2771329A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
| 09/02/2014 | US8822458 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/02/2014 | US8822435 Bisphosphonate compounds |
| 08/28/2014 | WO2014130411A1 Tgf-beta enhancing compositions for cartilage repair and methods related thereto |
| 08/28/2014 | WO2014130068A1 Methods for increasing oral ostenogenesis using lipoxin a4 (lxa4) and its analogs |
| 08/28/2014 | WO2014128497A1 Therapeutics for suppressing osteoporosis |
| 08/28/2014 | WO2014127418A1 Conjugate compound and uses of same |
| 08/28/2014 | US20140243284 Biologically active macrolides, compositions, and uses thereof |
| 08/27/2014 | EP2769718A1 Medicinal composition |
| 08/27/2014 | EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto |
| 08/27/2014 | EP2768859A1 Antagonists of il17c for the treatment of inflammatory disorders |
| 08/27/2014 | EP2768505A1 New salt and medical use |
| 08/26/2014 | US8816082 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
| 08/26/2014 | US8816073 Matrix metalloproteinase inhibitors |
| 08/26/2014 | US8815803 Method for increasing body height comprising systemic administration of CNP-53 |
| 08/26/2014 | CA2673253C Skin lightening composition for hyperpigmented skin |
| 08/26/2014 | CA2530631C Use of bacilli-class bacteria to produce a composition for the prevention of vertebral compression syndrome in salmonids |
| 08/22/2014 | CA2820562A1 Activating adipose-derived stem cells for transplantation |
| 08/21/2014 | WO2014126970A1 Serum fraction of platelet-rich fibrin |
| 08/21/2014 | WO2014126746A1 Phenoxyethoxy compounds |
| 08/21/2014 | WO2014126582A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF |
| 08/21/2014 | WO2014125413A1 Ip receptor agonist heterocyclic compounds |
| 08/21/2014 | WO2014087298A4 Novel selective androgen receptor modulators |
| 08/20/2014 | EP2767283A1 Therapeutic agent and preventive agent for demyelinating disease |